92 related articles for article (PubMed ID: 11062733)
1. Synergistic effects of danazol and mifepristone on the cytotoxicity of UCN-01 in hormone-responsive breast cancer cells.
Yokoyama Y; Shinohara A; Takahashi Y; Wan X; Takahashi S; Niwa K; Tamaya T
Anticancer Res; 2000; 20(5A):3131-5. PubMed ID: 11062733
[TBL] [Abstract][Full Text] [Related]
2. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
[TBL] [Abstract][Full Text] [Related]
3. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells.
El Etreby MF; Liang Y; Wrenn RW; Schoenlein PV
Breast Cancer Res Treat; 1998 Sep; 51(2):149-68. PubMed ID: 9879777
[TBL] [Abstract][Full Text] [Related]
4. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
5. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
[TBL] [Abstract][Full Text] [Related]
6. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
7. Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo.
Koh J; Kubota T; Koyama T; Migita T; Hashimoto M; Hosoda Y; Kitajima M
Breast Cancer; 2003; 10(3):260-7. PubMed ID: 12955040
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.
Mack PC; Gandara DR; Lau AH; Lara PN; Edelman MJ; Gumerlock PH
Cancer Chemother Pharmacol; 2003 Apr; 51(4):337-48. PubMed ID: 12721762
[TBL] [Abstract][Full Text] [Related]
9. Interactions between oestradiol and danazol on the growth of gastrointestinal tumour cells.
Watson SA; Crosbee DM; Dilks KL; Robertson JF; Hardcastle JD
Anticancer Res; 1993; 13(1):97-102. PubMed ID: 8476232
[TBL] [Abstract][Full Text] [Related]
10. UCN-01 (7-hydroxystaurosporine) inhibits the growth of human breast cancer xenografts through disruption of signal transduction.
Koh J; Kubota T; Migita T; Abe S; Hashimoto M; Hosoda Y; Kitajima M
Breast Cancer; 2002; 9(1):50-4. PubMed ID: 12196722
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
12. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
13. Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids.
Akoum A; Lemay A; Paradis I; Rheault N; Maheux R
Hum Reprod; 1996 Oct; 11(10):2269-75. PubMed ID: 8943541
[TBL] [Abstract][Full Text] [Related]
14. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function.
Shao RG; Cao CX; Shimizu T; O'Connor PM; Kohn KW; Pommier Y
Cancer Res; 1997 Sep; 57(18):4029-35. PubMed ID: 9307289
[TBL] [Abstract][Full Text] [Related]
16. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
Katsuki Y; Shibutani Y; Aoki D; Nozawa S
Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
[TBL] [Abstract][Full Text] [Related]
17. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitizing effect of tamoxifen and ICI 182,780 on parental and adriamycin-resistant MCF-7 human breast cancer cells.
de Vincenzo R; Scambia G; Benedetti Panici P; Bonanno G; Ercoli A; Fattorossi A; Pernisco S; Isola G; Mancuso S
Ann N Y Acad Sci; 1996 Apr; 784():517-20. PubMed ID: 8651609
[No Abstract] [Full Text] [Related]
19. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G(2) arrest.
Jones CB; Clements MK; Wasi S; Daoud SS
Cancer Chemother Pharmacol; 2000; 45(3):252-8. PubMed ID: 10663644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
